Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Canadian pharmaceutical company SaNOtize Research & Development Corp., (SaNOtize), and Glenmark Pharmaceuticals Limited (Glenmark), a global, innovation-driven pharmaceutical company, today announced successful results of Phase 3 clinical trials and approval from India's drug regulator for the treatment of adult patients with COVID-19 who have a risk of progression of the disease. The study confirmed that SaNOtize's Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that shortens the course of COVID-19, and could prevent the transmission of COVID-19. In a randomized, double-blind, placebo-controlled, parallel-arm study ... NONS reduced the SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours as compared to saline control. Treatment also demonstrated ... a statistically significant greater proportion of patients who achieved a combination of clinical and virological cure, based on the World Health Organization (WHO) Progression Scale. Moreover, the median time to negative PCR, in this group, was 4 days in the treatment group compared with 8 days in the control. Test subjects included patients infected with different variants, likely including Delta and Omicron. There were no significant adverse health events recorded. The reduction in log viral load corroborates the reduction of viral load in the UK Phase 2 trials (a reduction of 95% in 24 hours and 99% in 72 hours), conducted in March 2021.

Note: Why isn't this getting major attention in the media? Could it be because big Pharma will lose billions of dollars if this goes global? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Promotion of influenza vaccines is one of the most visible and aggressive public health policies today. Twenty years ago, in 1990, 32 million doses of influenza vaccine were available in the United States. Today around 135 million doses of influenza vaccine annually enter the US market, with vaccinations administered in drug stores, supermarkets–even some drive-throughs. This enormous growth has not been fueled by popular demand but instead by a public health campaign that delivers a straightforward ... message: influenza is a serious disease, we are all at risk of complications from influenza, the flu shot is virtually risk free, and vaccination saves lives. Yet across the country, mandatory influenza vaccination policies have cropped up, particularly in healthcare facilities, precisely because not everyone wants the vaccination, and compulsion appears the only way to achieve high vaccination rates. Closer examination of influenza vaccine policies shows that although proponents employ the rhetoric of science, the studies underlying the policy are often of low quality, and do not substantiate officials' claims. The vaccine might be less beneficial and less safe than has been claimed, and the threat of influenza appears overstated. Since 2000, the concept of who is "at risk" has rapidly expanded, incrementally encompassing greater swathes of the general population. Today, national guidelines call for everyone 6 months of age and older to get vaccinated. Now we are all "at risk."

Note: Full text available here. For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.

In the Arctic, microscopic particles of plastic are falling out of the sky with snow. Scientists said they were shocked by the sheer number of particles they found: more than 10,000 of them per litre in the Arctic. Even there, people are likely to be breathing in microplastics from the air. The health implications remain unclear. The region is often seen as one of the world's last pristine environments. A German-Swiss team of researchers has published the work in the journal Science Advances. The scientists also found rubber particles and fibres in the snow. Researchers collected snow samples from the Svalbard islands. In the laboratory ... they discovered far more contaminating particles than they'd expected. Many were so small that it was hard to ascertain where they had come from. The majority appeared to be composed of natural materials like plant cellulose and animal fur. But there were also particles of plastic, along with fragments of rubber tyres, varnish, paint and possibly synthetic fibres. The lead scientist, Dr Melanie Bergmann, told BBC News: "We expected to find some contamination but to find this many microplastics was a real shock." She said: "The majority of the microplastic in the snow comes from the air." Microplastics are defined as those particles below 5mm in size. Addressing their potential effects on people, Dr Bergmann explained: "We don't know if the plastics will be harmful to human health or not. But we need to take much better care of the way we're treating our environment."

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

Henry Dryer sits slumped over the tray attached to his wheelchair. He doesn't speak, and rarely moves, until a nursing home worker puts his headphones on. Then Dryer's feet start to shuffle, his folded arms rock back and forth, and he sings out loud in perfect sync with his favorite songs. "I feel a band of love, dreams," said Dryer, 92, who has dementia. "It gives me the feeling of love, romance!" Henry is one of seven patients profiled in the documentary "Alive Inside," a heartwarming look at the power of music to help those in nursing homes. "There are a million and a half people in nursing homes in this country," director Michael Rossato-Bennett told ABC News. "When I saw what happened to Henry, whenever you see a human being awaken like that, it touches something deep inside you." Rossato-Bennett said he took on the documentary project to promote Music & Memory, a nonprofit organization that brings iPods with personalized music to dementia patients in nursing home care. "When I end up in a nursing home, I'll want to have my music with me," said Dan Cohen, executive director of Music & Memory. "There aren't many things in nursing homes that are personally meaningful activities. Here's the one easy thing that has a significant impact." Cohen said the personalized playlists, chosen by loved ones, make patients light up. "They're more alert, more attentive, more cooperative, more engaged," he said. "Even if they can't recognize loved ones and they've stopped speaking, they hear music and they come alive."

Note: Don't miss this profoundly touching and inspiring documentary available here. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Henry Dryer, 92, is one of seven patients profiled in the documentary Alive Inside, a look at the power of music to help those with Alzheimer's. A clip of Dryer, who suffers from dementia, appears in an extraordinarily moving rough cut of the documentary that went up online this week. In the clip, which has been viewed 3 million times already, Dryer is largely mute and slumped over. He does not recognize his own daughter. But when a caregiver places a pair [of] headphones on him, he undergoes an astonishing transformation. His face, formerly slack and inert, lights up. His eyes beam, and he sways in his chair, keening along to the music of his youth. The effect lasts even after the headphones are removed. "I'm crazy about music," Dryer says. "I guess Cab Calloway was my number one band guy." Music "gives me the feeling of love", Dryer says. Author and neurologist Oliver Sacks, who has written extensively about the effects of music on the human brain, watches Dryer. "In some sense, Henry is restored to himself. He remembers who he is. He has reaquired his identity for a while through the power of music," Sacks says in the Alive Inside clip. "There are a million and a half people in nursing homes in this country," Alive Inside director Michael Rossato-Bennett told ABC News. "When I saw what happened to Henry, whenever you see a human being awaken like that, it touches something deep inside you."

Note: Don't miss this profoundly touching and inspiring documentary available here. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Four African countries have reported new cases of polio linked to the oral vaccine, as global health numbers show there are now more children being paralyzed by viruses originating in vaccines than in the wild. In a report late last week, the World Health Organization and partners noted nine new polio cases caused by the vaccine in Nigeria, Congo, Central African Republic and Angola. Seven countries elsewhere in Africa have similar outbreaks and cases have been reported in Asia. Of the two countries where polio remains endemic, Afghanistan and Pakistan, vaccine-linked cases have been identified in Pakistan. In rare cases, the live virus in oral polio vaccine can mutate into a form capable of sparking new outbreaks. All the current vaccine-derived polio cases have been sparked by a Type 2 virus contained in the vaccine. Type 2 wild virus was eliminated years ago. WHO and partners have long relied on oral polio vaccines because they are cheap and can be easily administered. Western countries use a more expensive injectable polio vaccine that contains an inactivated virus incapable of causing polio. The Independent Monitoring Board, a group set up by WHO to assess polio eradication, warned in a report this month that vaccine-derived polio virus is "spreading uncontrolled in West Africa." The group said officials were already "failing badly" to meet a recently approved polio goal of stopping all vaccine-derived outbreaks within 120 days of detection.

Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.

Depression among adults in the United States tripled in the early 2020 months of the global coronavirus pandemic–jumping from 8.5 percent before the pandemic to a staggering 27.8 percent. New research from Boston University School of Public Health reveals that the elevated rate of depression has persisted into 2021, and even worsened, climbing to 32.8 percent and affecting 1 in every 3 American adults. The study is the first nationally representative study in the US that examines the change in depression prevalence before and then during the pandemic. Published in the journal The Lancet Regional Health–Americas, the study found that the most significant predictors for if a person experienced depressive symptoms during the pandemic were low household income, not being married, and experiencing multiple pandemic-related stressors. "The sustained high prevalence of depression does not follow [the same] patterns [we observed] after previous traumatic events, such as Hurricane Ike," says study senior author Sandro Galea. "Typically, we would expect depression to peak following the traumatic event and then lower over time. Instead, we found that 12 months into the pandemic, levels of depression remained high." The burden of depression intensified over the course of the pandemic and disproportionately impacted adults with lower incomes. By spring 2021, low-income adults were 7 times more likely to experience [elevated depressive] symptoms.

Note: Note that this huge increase in depression was caused not directly by the pandemic, but more by the isolation of the lockdown measures instituted. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Did you ever feel your own shoulders relax when you saw a friend receive a shoulder massage? For those of you who said "yes," congratulations, your brain is using its power to create a "placebo effect." For those who said "no," you're not alone, but thankfully, the brain is trainable. Since the 1800s, the word placebo has been used to refer to a fake treatment, meaning one that does not contain any active, physical substance. Today, placebos play a crucial role in medical studies in which some participants are given the treatment containing the active ingredients of the medicine, and others are given a placebo. These types of studies help tell researchers which medicines are effective, and how effective they are. Surprisingly, however, in some areas of medicine, placebos themselves provide patients with clinical improvement. Research suggests that the placebo effect is caused by positive expectations, the provider-patient relationship and the rituals around receiving medical care. Depression, pain, fatigue, allergies, irritable bowel syndrome, Parkinson's disease and even osteoarthritis of the knee are just a few of the conditions that respond positively to placebos. In addition to the ever-increasing body of evidence surrounding their effectiveness, placebos offer multiple benefits. They have no side effects. They are cheap. They are not addictive. They provide hope when there might not be a specific chemically active treatment available. They mobilize a person's own ability to heal through multiple pathways.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Like many paediatricians, Dani Dumitriu braced herself for the impact of the SARS-CoV-2 coronavirus when it first surged in her wards. She was relieved when most newborn babies at her hospital who had been exposed to COVID-19 seemed to do just fine. But hints of a more subtle and insidious trend followed close behind. Dumitriu and her team ... had more than two years of data on infant development – since late 2017, they had been analysing the communication and motor skills of babies up to six months old. Dumitriu thought it would be interesting to compare the results from babies born before and during the pandemic. The infants born during the pandemic scored lower, on average, on tests of gross motor, fine motor and communication skills compared with those born before it. It didn't matter whether their birth parent had been infected with the virus or not; there seemed to be something about the environment of the pandemic itself. Lockdowns ... have isolated many young families, robbing them of playtime and social interactions. Stressed out and stretched thin, many carers also haven't been able to provide the one-to-one time that babies and toddlers need. Worryingly, [biophysicist Sean] Deoni has found that the longer the pandemic has continued, the more deficits children have accumulated. "The magnitude is massive – it's just astonishing," Deoni says of the findings, which are now under revision in JAMA Pediatrics.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Inspired by a parasitic worm that digs its sharp teeth into its host's intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body. David Gracias, a professor in the Whiting School of Engineering, and gastroenterologist Florin M. Selaru, director of the Johns Hopkins Inflammatory Bowel Disease Center, led a team of researchers and biomedical engineers that designed and tested shape-changing microdevices that mimic the way the parasitic hookworm affixes itself to an organism's intestines. The "theragrippers" are made of metal and a thin, shape-changing film, then coated in heat-sensitive paraffin wax. The devices, each roughly the size of a dust speck, can potentially carry any drug and release it gradually into the body. Thousands of theragrippers can be deployed in the GI tract. When the paraffin wax coating on the grippers reaches the temperature inside the body, the devices close autonomously and clamp onto the colonic wall. The closing action causes the tiny, six-pointed devices to dig into the mucosa and remain attached to the colon, where they are retained and release their medicine payloads gradually into the body. Theragrippers, says Gracias, don't rely on electricity, wireless signals or external controls. "Instead, they operate like small, compressed springs with a temperature-triggered coating on the devices that releases the stored energy autonomously."

Note: These tiny devices are literally the size of a speck of dust. They can easily be hidden in a cotton swab and administered without a person's knowledge. Might they even be put in a vaccine and go undetected? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

COVID-19 is a global pandemic. Treatment with hydroxychloroquine (HCQ), zinc, and azithromycin (AZM), also known as the Zelenko protocol, and treatment with intravenous (IV) vitamin C (IVC) have shown encouraging results in a large number of trials worldwide. In addition, vitamin D levels are an important indicator of the severity of symptoms in patients with COVID-19. Hospitalized patients with COVID-19 ... were screened for eligibility and randomly allocated to receive either HCQ, AZM, and zinc (group 1) or HCQ, AZM, zinc plus IV vitamin C treatment (group 2) for 14 days. The patients also received nontherapeutic levels of vitamin D3. A total of 237 hospitalized patients with COVID-19 ... were enrolled in the study. Almost all patients were vitamin D deficient (97%). All but one patient (99.6%; n = 236/237) treated with HCQ, AZM, and zinc with or without high-dose IV vitamin C (IVC) fully recovered. Additional IVC therapy contributed significantly to a quicker recovery (15 days versus 45 days until discharge; p = 0.0069). Low vitamin D levels were significantly correlated with a higher probability of admission to the intensive care unit (ICU) and longer hospital stay. Our study suggests that the treatment protocol of HCQ, AZM, and zinc with or without vitamin C is safe and effective in the treatment of COVID-19, with high dose IV vitamin C leading to a significantly quicker recovery.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Massachusetts health officials on Tuesday reported ... 290 more deaths in people with breakthrough cases. In the last week, 27,530 new breakthrough cases - infections in people who have been vaccinated - were reported, with 555 more vaccinated people hospitalized over the period. It's a 40% drop in the rate of new breakthrough cases in Massachusetts - the previous week saw 46,092 new COVID infections in vaccinated people. On Tuesday ... there were 127 new deaths reported -- a statistic that includes three days because of the weekend -- bringing the death toll to 21,546. The seven-day average test positivity stands at 7.13%. In December, Massachusetts Department of Public Health officials released a study that found that 97% of breakthrough cases in the state did not become severely ill and rarely led to deaths, especially among young people. Massachusetts' COVID metrics, tracked on the Department of Public Health's interactive coronavirus dashboard, have been trending downward after spiking to heights not seen since previous surges, a peak thought to be driven at least in part by the omicron variant.

Note: As of Jan. 31, 2022, Massachusetts had a total of 21,546 COVID deaths as reported above. Their first COVID death was on Mar. 20, 2020. So over the 97 weeks since the start of the pandemic, they averaged 222 deaths a week. Yet in the last week of January 2022, this NBC article reports 290 breakthrough deaths. So the number of deaths among the vaccinated in that one week was greater than the average weekly number of deaths for the whole pandemic. Weren't these vaccines supposed to be 90% effective or more?

In May, a long-awaited randomized, double-blind, placebo-controlled, Phase 3 clinical trial testing MDMA-assisted therapy for the treatment of PTSD was published in Nature Medicine. The trial was conducted by MAPS Public Benefit Corporation, a for-profit subsidiary launched by the registered non-profit in 2014, with the goal of conducting the necessary research to make MDMA a legally available medicine. "We are a for-profit, but we're wholly owned. We only have one shareholder, and it's a non-profit," says CEO Amy Emerson. While a non-profit is tax exempt and operates for charity, the PBC, like a traditional corporation, pays taxes, operates for profit, and has shareholders and stocks. The results of the Phase 3 clinical trial conducted by MAPS PBC revealed that after receiving a combination of talk therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 percent of participants who received the placebo. The trial was recently acknowledged as a "big win for the field" in Science Magazine's annual Breakthrough of the Year awards. "In our three-session model, there's no follow-up medication needed," [MAPS CMO Dr. Corine de Boer] says. After pooling the data of six Phase 2 trials together, de Boer's team found that 57 percent of participants no longer met the criteria for PTSD. At a one-year follow-up during which no MDMA was administered, that number increased to 67 percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

McMaster Children's Hospital says it has seen a steady increase of youth in crisis since the COVID-19 pandemic began. Youth admitted for medical support after a suicide attempt has tripled over a four-month period, compared to last year. The hospital also said that patients are staying in hospital longer due to more serious attempts. A large number of these youth have reported COVID-related issues such as lack of social interaction, increased conflict at home, and the inability to rely on friends as main contributors. Over the same time period, youth admitted with substance use disorders has doubled compared to last year. In particular, the use of potentially deadly opioids has increased. The number of cases admitted to hospital with predominant symptoms of psychosis has doubled, with the large majority related to substance use. Meanwhile, McMaster Children's Hospital says referrals to its Eating Disorders Program have increased by 90 per cent in a four-month period, compared to last year. Admissions are projected to increase by 33 per cent over the 12-months since the pandemic started. "It's unprecedented," says clinical manager Paul Agar.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters "can be done once, or maybe twice, but it's not something that we can think should be repeated constantly," Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. "We need to think about how we can transition from the current pandemic setting to a more endemic setting."

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Pregnant women have long been assured that acetaminophen can treat their aches, pains and fevers without bringing harm to the babies they carry. Now researchers say they have found a strong link between prenatal use of the medication and cases of attention-deficit hyperactivity disorder in children. The results, published ... in the journal JAMA Pediatrics, add to growing evidence that the active ingredient in Tylenol may influence brain development in utero. But they do not provide clear answers for mothers-to-be or their doctors about whether acetaminophen is safe during pregnancy. In analyzing data on more than 64,000 Danish women and their children, researchers found that kids whose mothers took the painkiller at any point during pregnancy were 29% more likely to be diagnosed with ADHD than were kids whose mothers took none. The risk increased the most – by 63% – when acetaminophen was taken during the second and third trimesters, and by 28% when used in the third trimester alone. But when taken only in the first trimester, the added risk was 9%. Members of the research team had long suspected that acetaminophen may behave as an endocrine-disrupting chemical capable of influencing fetal brain development. The drug is known to cross the placental barrier between mother and fetus, and some studies have found higher rates of male babies with undescended testicles born to women who took it during pregnancy.

Note: Another study on Tylenol found a two-fold increase in risk of children being born with both ADHD and autism. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

After 30 years of immunology research, [Louis Picker] is on the verge of launching human trials for a vaccine that could stop AIDS, an epidemic that has become something of an afterthought decades after it began ravaging gay men in America. For many in the developed world, complacency has set in, largely thanks to a regimen of antiretroviral drugs that allow people with HIV to live long and healthy lives, and decades of failed attempts to develop a vaccine. In 1984, U.S. Secretary of Health and Human Services Margaret Heckler expressed hope ... that science might have a vaccine for HIV within two years. Instead, a decade passed, and by 1994, AIDS was the leading cause of death for Americans ages 25 to 44. Four vaccines have made it to human trials, but none made it to market. As Picker continued his research, scientists developed a series of antiretroviral drugs that slowly downgraded HIV to a chronic disease ... in the developed world. But globally, AIDS is still killing a lot of people, largely because most of those infected in poorer countries don't have access to the drugs. According to the World Health Organization, 1.1 million people died from AIDS in 2015. In the U.S., 50,000 new cases of HIV are reported every year. Worldwide, the number is 2 million. Every time news reports come out about Picker's research, he fields a series of phone calls from HIV-infected patients, their friends and their family. "Can I be in your trial?" people ask him. "Please, can you save my son?"

Note: How is it that COVID-19 vaccines were created just months after it became a threat while many decades later no vaccine has been found for the deadly AIDS epidemic, which according to the WHO has killed 36 million - many times the number of deaths from COVID? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

A year ago, just two doses of a Covid-19 vaccine – or even one, in the case of Johnson & Johnson's formulation – were thought to offer sufficient protection against the coronavirus. On Wednesday, the Centers for Disease Control and Prevention expanded eligibility for boosters to adolescents and backed away from describing anyone as "fully vaccinated" because two shots no longer seem adequate. Instead, one's vaccination status will now be "up to date" – or not. It's no surprise that many Americans are wondering: Where does this end? Are we to roll up our sleeves for booster shots every few months? Scientists are reluctant to predict the future. But in interviews this week, nearly a dozen said that whatever happens, trying to boost the entire population every few months is not realistic. Nor does it make much scientific sense. For starters, persuading people to line up for shots every few months is probably a losing proposition. Just as important, there are no data to support the effectiveness of a fourth dose of the current vaccines. If the coronavirus settles into a flulike seasonal pattern, as it seems possible, "you can imagine a scenario where we simply give boosters before the winter each year," Dr. Hensley said. Lessons from flu season also suggest that frequent vaccination is unlikely to be helpful. Giving the flu vaccine twice a year "has a diminishing return, and so it may not make sense to do vaccination so frequently," said [epidemiologist] Ben Cowling.

Note: Could it be that this is what big Pharma has been hoping for all along - forever boosting? And if it's all free, you won't even see how billions of your tax dollars are flowing into the pockets of the elite. Could this be why the Australian government on their website stated they are securing 195 million doses of COVID vaccine boosters for their population of 25 million? For more, see this revealing article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Psychedelics startups don't just want to just reinvent mental health. They also want to reinvent capitalism. And judging by the news coming out of last week's "Horizons: Perspectives on Psychedelics" conference in Manhattan, they're having some early success. Stephen Jurvetson, co-founder of Future Ventures and a board member at SpaceX, told me ... that he's a true believer in the industry's mission to fix the state of mental-health care. He decided last week to carve up his own estate by giving around half of his net worth to fund psychedelic science. Organizations like the public-benefit corporation of Multidisciplinary Association for Psychedelics Studies, or MAPS, and the Psychedelic Science Funders Collaborative, a nonprofit organization, have both accepted charitable donations but fund research that could lead to blockbuster drugs. Psychedelics startups do need funding, and badly. Like biotech, it's a high-risk industry with expensive clinical trials and regulatory uncertainty. And patents, a traditional financial engine for biotech, are harder to win for plants that have been around for centuries, or molecules that have already made the rounds as street drugs. MAPS also made a major announcement: The New York-based venture capital fund Vine Ventures has created a $70 million special purpose vehicle to fund its Phase 3 clinical trials on post-traumatic stress disorder and MDMA. The novel funding method ... will help keep MAPS a nonprofit while letting it retain control of its intellectual property.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

Legal psychedelic medicine is poised to soon disrupt the multibillion-dollar mental health field. Treatments being trialed today in clinical settings using substances like psilocybin-containing mushrooms will soon offer legal alternatives to the more than 50 percent of patients receiving therapy for major depressive disorder (MDD) who do not respond to approved depression medications. The creation of new effective therapies will likely put pressure on healthcare providers to examine the upside of psychedelic therapies and how such treatments will inevitably affect their bottom line. While these therapies will not be a cure-all for everyone, over the next three to five years an expanding number of psychedelic treatments will produce alternatives for the many patients who find no relief from FDA-approved, first-line therapeutics like selective serotonin reuptake inhibitors (SSRIs). Since legalizing the use of psilocybin-containing magic mushrooms in 2020 through a ballot measure, Oregon is now in the process of creating an intricate statewide system for qualified caregivers to deliver psilocybin treatments in therapeutic settings. Sessions using psilocybin can last over six hours, which does not include vital therapy before and after treatments. MDMA-assisted therapy for severe post-traumatic stress disorder (PTSD), which is very close to being an FDA-approved therapy, will likewise require significant clinician involvement before, during and after a session.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.